Table 1.

Risk factors associated with complicated forms (N = 17).

	Clinical presentation
	Uncomplicated (n = 6)		Complicated (n = 11)
	mean	[SD]	mean	[SD]	p-value	ORAdj	[IC 95%]	p
Age	84.8	[16]	82.7	[10.7]	0.748
Symptoms onset (days)	4.2	[5.51]	4.4	[3.72]	0.930
Lymphocyte T CD4+ (%)	44.9	[14.21]	38.4	[16.09]	0.419
L. T CD8+ (%)	22.2	[15.15]	20.1	[12.5]	0.767
L. T CD4+CD8+ (%)	3.4	[2.87]	2.1	[1.14]	0.197
L. CD4-CD8- (%)	1.4	[1.35]	3.6	[2.93]	0.108
L. NK (%)	23.0	[13.36]	26.97	[17.73]	0.641
L. T CD56+ (%)	3.2	[1.63]	7.8	[5.78]	0.314
L. T CD5+ (%)	14.0	[11.77]	5.4	[4.74]	0.786
L. T CD4CD38HLADR (%)	3.0	[1.97]	5.4	[8.67]	0.506
L. T CD8CD38HLADR (%)	13.2	[13.14]	13.3	[15.51]	0.993
L. T regulators (%)	3.0	[1.15]	2.6	[0.80]	0.465
L. B CD19+ kappa (%)	61.7	[3.21]	58.0	[7.20]	0.300
L. B CD19+ lambda (%)	37.7	[3.54]	41.7	[7.14]	0.266
L. B CD19+ CD20+ (%)	97.3	[2.82]	97.5	[4.26]	0.922
L. B CD19+ CD10+ (%)	5.8	[4.85]	2.0	[2.34]	0.046
L. T CD4 naive (%)	34.6	[17.07]	28.3	[14.75]	0.439
L. T CD4 central memory (%)	36.0	[18.67]	39.0	[18.71]	0.756
L. T CD4 effector memory (%]	26.3	[20.33]	30.2	[22.59]	0.726
L. T CD4 EMRA* (%)	3.1	[3.37]	5.4	[10.97]	0.627
L. T CD8 naive (%)	12.4	[10.70]	16.7	[21.36]	0.653
L. T CD8 CM (%)	10.3	[19.79]	5.9	[3.75]	0.473
L. T CD8 EM (%)	25.8	[13.31]	37.2	[16.55]	0.168
L. T CD8 EMRA* (%)	51.5	[27.97]	40.2	[16.62]	0.308

	n	%	n	%	p-value	ORAdj	[IC 95%]	p
Gender					0.399
Men	2	(33.3)	6	(54.5)
Women	4	(66.7)	5	(45.5)
Hypertension					0.113
Yes	2	(33.3)	8	(72.7)
No	4	(66.7)	3	(27.3)
Diabetes					0.219
Yes	1	(16.7)	5	(45.5)
No	5	(83.3)	6	(54.5)
Cognitive disorders					0.174
Yes	3	(50.0)	2	(18.2)
No	3	(50.0)	9	(81.8)
Obesity					0.515
Yes	0	(0)	2	(18.2)
No	6	(100.0)	9	(81.8)
Total lymphocyte count >1000 cc/mm3
Yes	5	(83.3)	5	(45.5)	0.116
No	5	(16.7)	6	(54.5)
L. B CD19+ CD10+ > 3%					0.007
No	1	(16.7)	9	(81.8)		1
Yes	5	(83.3)	2	(18.2)		0.04	[0.002;0.795]	0.034

^*EMRA: effector memory CD45 + RA cells.